Follow-up (mo) | |
Median | 24 |
Range | 1–103 |
Survival (mo) | |
Median | 20 |
Range | 0–93 |
Survival status at last follow-up (n) | |
Alive | 182 (50) |
Dead | 180 (50) |
Primary cancer | 166 (45.9) |
Incidental 18F-FDG–avid TI | 1 (0.3) |
Nonmaligant etiology | 13 (3.6) |
18F-FDG–avid TI status at last follow-up (n) | |
Malignant TI | 47 (13) |
Observation | 11 (3) |
No clinically evident disease | 31 (9) |
Recurrent/metastatic structural disease | 1 (0.3) |
Metastasis (from underlying malignancy) | 4 (1) |
Nondiagnostic/indeterminate FNA | 12 (3) |
Benign TI | 72 (20) |
Not investigated | 231 (64) |